Scientists at Scripps Research have found that a mutation called G186V could be a useful addition to the H3N2 influenza vaccine. As they reported in Cell Host & Microbe, preparing a seasonal flu vaccine with the G186V mutation may prevent a vexing problem that commonly occurs during the vaccine manufacturing process.
↧